 Participants in this study will include African Americans with RA and healthy African Americans with RA. There are two arms: 1 longitudinal; and 2 cross-sectional. The longitudinal arm has completed enrollment and is still in the follow-up phase. This consists of visits at baseline less than 2 years disease duration; 3 years disease duration; and 5 years disease duration. 